Abstract
Our laboratory has established that the free radical signaling molecule nitric oxide (NO) is an endogenous regulator of epigenetic methylation through direct inhibition of the Fe(II)/2-oxoglutarate-dependent dioxygenase (2-ODD) family, including histone demethylases (KDMs)[1, 2], mRNA demethylases (FTO, ALKBH5) [3], and DNA demethylases (TETs, ALKBH2) [4]. We previously showed that NO alters 38 histone post-translational modifications (PTMs) and genome-wide transcription in breast cancer cells [3]. Here, we comprehensively quantify 76 histone modifications, including 30 combinatorial marks on adjacent residues not resolved in the original analysis, and systematically profile methyl-modifying enzyme expression. We identify four coordinated histone PTM axes converging on a chromatin compaction signature: (i) H3K9 methylation accumulation with selective K9me1K14ac remodeling, (ii) H4K20me1→me2/me3 conversion, (iii) a novel H3K27-K36 combinatorial landscape shift, and (iv) preferential depletion of hyperacetylated H4 species. A composite Chromatin Compaction Score integrating all 76 PTMs with literature-based valence assignments confirms progressive compaction, validated independently by PCA. ChIP-seq reanalysis reveals that H3K9me2 accumulates predominantly at intergenic regions while K9ac undergoes activity-dependent redistribution governed by baseline chromatin state, with near-perfect reciprocal H3K9me2 gain at silent loci. Systematic enzyme profiling shows coordinated upregulation of 13/18 detected KDMs alongside methyltransferase downregulation, a compensatory response that fails to overcome direct enzymatic inhibition by NO. This compaction signature is associated with tumor-permissive gene silencing: DNA repair genes are downregulated, chromatin remodeling complexes suppressed, and IDH1 downregulation creates a feed-forward loop compounding 2-ODD inhibition. These findings establish NO-mediated KMD inhibition as a driver of coordinated chromatin compaction linked to pro-tumorigenic gene silencing.